Xue Tian
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 5
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Blood Pressure and Hypertension Studies 7
- Cardiovascular Health and Disease Prevention 7
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Obstetrics and Gynecology top 10%
-
- Acute Ischemic Stroke Management 8
-
- Cerebrovascular and Carotid Artery Diseases 6
-
- Lipoproteins and Cardiovascular Health 5
- Co-authors
- Yingting ZuoShuohua ChenShouling WuAnxin WangBoni TaoQian LiuYongjun WangWuping Bao
- Journals
- SHILAP Revista de lepidopterología (4 papers)Annals of Internal Medicine (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xue Tian
73 papers receiving 894 citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Nephrology 88
- Endocrinology, Diabetes and Metabolism 177
- Cardiology and Cardiovascular Medicine 212
- Obstetrics and Gynecology 42
- Internal Medicine 20
Countries citing papers authored by Xue Tian
This map shows the geographic impact of Xue Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Tian more than expected).
Fields of papers citing papers by Xue Tian
This network shows the impact of papers produced by Xue Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Tian. The network helps show where Xue Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 33 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 9 | |
| 17 | Carbapenem-Resistant Enterobacter cloacae Causing Nosocomial Infections in Southwestern China: Molecular Epidemiology, Risk Factors, and Predictors of Mortality | 2020 | 1 |
| 18 | 2020 | 11 | |
| 19 | 2020 | 4 | |
| 20 | 2007 | 5 |
About Xue Tian
Xue Tian is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 83 papers that have together received 904 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (8 papers), Blood Pressure and Hypertension Studies (7 papers), Cardiovascular Health and Disease Prevention (7 papers), Cerebrovascular and Carotid Artery Diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). The work is most often cited by research in Nephrology (88 citations), Endocrinology, Diabetes and Metabolism (177 citations) and Cardiology and Cardiovascular Medicine (212 citations). Xue Tian has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yingting Zuo, Shuohua Chen, Shouling Wu, Anxin Wang, Boni Tao, Qian Liu, Anxin Wang, Yongjun Wang, Wuping Bao and Fengming Ding. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.